Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ami Fishman

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Gynecologic Oncology|January 29, 2002
Papillary serous carcinoma of the peritoneum coexisting with or after endometrial carcinomaMarco M Altaras, Joelle Bernheim, Tania Zehavi, et al.
Plos One|April 27, 2013
Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent mannersRive Sarfstein, Yael Friedman, Zohar Attias-Geva, et al.
Human Reproduction (Oxford, England)|October 9, 2004
The morphological normalcy of the sperm nucleus and pregnancy rate of intracytoplasmic injection with morphologically selected spermArie Berkovitz, Fina Eltes, Shlomit Yaari, et al.
Archives of Gynecology and Obstetrics|May 8, 2014
Patients with high-risk pregnancies and complicated deliveries have an increased risk of maternal postpartum readmissionsMerav Sharvit, Tamar Rubinstein, Dorit Ravid, et al.
Surgical Oncology|August 11, 2020
Time interval from biopsy to surgery and risk for adjuvant therapy in patients with low-risk endometrial cancerYfat Kadan, Aula Asali, Ami Fishman, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2011
Insulin-like growth factor-I receptor (IGF-IR) targeting with monoclonal antibody cixutumumab (IMC-A12) inhibits IGF-I action in endometrial cancer cellsZohar Attias-Geva, Itay Bentov, Dale L Ludwig, et al.
Archives of Gynecology and Obstetrics|July 25, 2019
Placental supernatants' enhancement of the metastatic potential of breast cancer cells: is estrogen receptor (ERα) essential for this phenomenon?Michal Bar, Oded Komemi, Meir Pomeranz, et al.
Plos One|May 24, 2019
Postcoital bleeding is a predictor for cervical dysplasiaOmer Cohen, Edwardo Schejter, Regina Agizim, et al.
Journal of Clinical Ultrasound : JCU|February 4, 2005
Uterine sarcomas versus leiomyomas: gray-scale and Doppler sonographic findingsRami Aviram, Yifat Ochshorn, Ofer Markovitch, et al.
Cancer Letters|February 14, 2013
IGF1R-directed targeted therapy enhances the cytotoxic effect of chemotherapy in endometrial cancerConnie Bitelman, Rive Sarfstein, Menahem Sarig, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Gynecologic Oncology|January 29, 2002
Papillary serous carcinoma of the peritoneum coexisting with or after endometrial carcinomaMarco M Altaras, Joelle Bernheim, Tania Zehavi, et al.
Plos One|April 27, 2013
Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent mannersRive Sarfstein, Yael Friedman, Zohar Attias-Geva, et al.
Human Reproduction (Oxford, England)|October 9, 2004
The morphological normalcy of the sperm nucleus and pregnancy rate of intracytoplasmic injection with morphologically selected spermArie Berkovitz, Fina Eltes, Shlomit Yaari, et al.
Archives of Gynecology and Obstetrics|May 8, 2014
Patients with high-risk pregnancies and complicated deliveries have an increased risk of maternal postpartum readmissionsMerav Sharvit, Tamar Rubinstein, Dorit Ravid, et al.
Surgical Oncology|August 11, 2020
Time interval from biopsy to surgery and risk for adjuvant therapy in patients with low-risk endometrial cancerYfat Kadan, Aula Asali, Ami Fishman, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2011
Insulin-like growth factor-I receptor (IGF-IR) targeting with monoclonal antibody cixutumumab (IMC-A12) inhibits IGF-I action in endometrial cancer cellsZohar Attias-Geva, Itay Bentov, Dale L Ludwig, et al.
Archives of Gynecology and Obstetrics|July 25, 2019
Placental supernatants' enhancement of the metastatic potential of breast cancer cells: is estrogen receptor (ERα) essential for this phenomenon?Michal Bar, Oded Komemi, Meir Pomeranz, et al.
Plos One|May 24, 2019
Postcoital bleeding is a predictor for cervical dysplasiaOmer Cohen, Edwardo Schejter, Regina Agizim, et al.
Journal of Clinical Ultrasound : JCU|February 4, 2005
Uterine sarcomas versus leiomyomas: gray-scale and Doppler sonographic findingsRami Aviram, Yifat Ochshorn, Ofer Markovitch, et al.
Cancer Letters|February 14, 2013
IGF1R-directed targeted therapy enhances the cytotoxic effect of chemotherapy in endometrial cancerConnie Bitelman, Rive Sarfstein, Menahem Sarig, et al.
Pageof 8